- Home
- DTST vs ESLA Comparison
DTST vs ESLA Comparison
Compare DTST & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- ESLA
- Stock Information
- Founded
- DTST 2001
- ESLA 2021
- Country
- DTST United States
- ESLA United States
- Employees
- DTST N/A
- ESLA N/A
- Industry
- DTST EDP Services
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DTST Technology
- ESLA Health Care
- Exchange
- DTST Nasdaq
- ESLA Nasdaq
- Market Cap
- DTST 33.4M
- ESLA 35.5M
- IPO Year
- DTST N/A
- ESLA N/A
- Fundamental
- Price
- DTST $4.68
- ESLA $0.85
- Analyst Decision
- DTST
- ESLA Strong Buy
- Analyst Count
- DTST 0
- ESLA 1
- Target Price
- DTST N/A
- ESLA $16.00
- AVG Volume (30 Days)
- DTST 984.8K
- ESLA 17.6K
- Earning Date
- DTST 08-14-2025
- ESLA 08-20-2025
- Dividend Yield
- DTST N/A
- ESLA N/A
- EPS Growth
- DTST N/A
- ESLA N/A
- EPS
- DTST 0.02
- ESLA N/A
- Revenue
- DTST $25,219,312.00
- ESLA N/A
- Revenue This Year
- DTST $12.57
- ESLA N/A
- Revenue Next Year
- DTST $9.29
- ESLA N/A
- P/E Ratio
- DTST $195.72
- ESLA N/A
- Revenue Growth
- DTST N/A
- ESLA N/A
- 52 Week Low
- DTST $2.93
- ESLA $0.63
- 52 Week High
- DTST $5.57
- ESLA $1.81
- Technical
- Relative Strength Index (RSI)
- DTST 59.06
- ESLA 45.00
- Support Level
- DTST $4.61
- ESLA $0.82
- Resistance Level
- DTST $4.87
- ESLA $0.95
- Average True Range (ATR)
- DTST 0.34
- ESLA 0.07
- MACD
- DTST -0.01
- ESLA 0.00
- Stochastic Oscillator
- DTST 63.64
- ESLA 44.06
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.